United States · Series D startup
5 rounds we have observed, with the 7 investors named in them. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.
Funding summaryUpdated 26 Oct 2026
$9.3Mraised across 5 rounds since 2006, from 5 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Reported by smartinsulin.comSEC filing: $1.7M sold, first sale Mar 2010
No investor was named in the report.
From a historical funding recordSEC filing: $1.1M sold, first sale Jul 2009
Cherrystone Angel
Boston Harbor Angels
Angel Healthcare Investors
Beacon Street CapitalFrom a historical funding recordSEC filing: $1.1M sold, first sale Jul 2009
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Cherrystone AngelBoston Harbor AngelsAngel Healthcare InvestorsBeacon Street CapitalCommon AngelsCommonAngels VenturesCherrystoneFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
SmartCells's investors include Cherrystone Angel, Boston Harbor Angels, Angel Healthcare Investors, Beacon Street Capital and Common Angels, and 2 more on record.
SmartCells has raised $9.3M across 5 rounds since 2006. 2 rounds did not disclose an amount, so the total is a floor.
SmartCells's most recent round was a Series D of $4.1M in Jun 2010.
Its most recent round, $4.1M in Jun 2010, is also its largest on record.
SmartCells's first round on record, in May 2006, was backed by Cherrystone Angel.
SmartCells's latest named round is a Series D, in Jun 2010.
SmartCells is based in the United States.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States ·